The same datasets we build our client models on, maintained and published as a subscription. Every figure traces to a named public source under a licence checked for commercial use, and the method is published alongside the data rather than kept behind it.
Starter and Professional are single named users. Enterprise covers everyone at your organisation, with no seats to administer.
The context layer: what health systems spend, what patients can afford, what agencies approve and how many people have the disease.
Everything we publish, for one named person. The full set of thirteen products, portal and API.
The same thirteen products for your whole organisation, with unmetered API access and no seat to manage.
Prices are annual, in GBP, and exclude VAT where it applies. Access is granted the moment payment clears. Subscriptions renew annually and can be cancelled at any point before renewal, with access running to the end of the paid term.
Thirteen products, refreshed on published cadences. Every one is available through the portal and through the API.
| Product | Starter | Professional | Enterprise |
|---|---|---|---|
| HTA OutcomesReimbursement decisions across eleven agencies, UK to Australasia to LatAm | ✓ | ✓ | ✓ |
| EpidemiologyPrevalence and incidence, with the systematic review map | ✓ | ✓ | ✓ |
| Global Health SystemsExpenditure, workforce and capacity by country | ✓ | ✓ | ✓ |
| Affordability TrackerWhat treatment costs against ability to pay | ✓ | ✓ | ✓ |
| Drug Sales & ClassesProduct and class sales, globally and by region | – | ✓ | ✓ |
| MedTech IntelligenceDevice segment revenue by company, area and region | – | ✓ | ✓ |
| Procedure VolumesSurgical and procedure activity, US and England | – | ✓ | ✓ |
| Biopharma IntelligencePipeline assets, comparators and company dossiers | – | ✓ | ✓ |
| Trade & PricingTariffs and international reference pricing rules | – | ✓ | ✓ |
| Market UpdatePrescribing uptake by molecule and geography | – | ✓ | ✓ |
| Pathway ProbabilitiesBayesian odds of clearing each gate to reimbursement | – | ✓ | ✓ |
| Regulatory ApprovalsFDA, EMA and PMDA approval dates with measured HTA lag per molecule | – | ✓ | ✓ |
| Trial IntelligenceIndustry trials phase 2 and above since 2010, with design norms and sponsor landscape | – | ✓ | ✓ |
A gated web portal for reading and charting, and a JSON API for putting the data inside your own models. Both carry the same subscription, so you are not paying twice. API documentation is in the portal.
Starter and Professional are licensed to one named person, who signs in with their work email. Enterprise covers everyone at your organisation's email domain, with nobody to add or remove. Extra named users can be added to any plan; ask us.
Official and public sources: national statistics, regulators, HTA agencies, company filings and registries. We publish the full source and licence position for every dataset, including the places where a licence stops us republishing something.
Use it for your own analysis, internally, without limit. It is not licensed for redistribution, resale, or inclusion in a product you sell on. Some sources also require attribution, which we set out per dataset.
Yes. If the tiers do not fit, tell us what you actually need and we will price it. Most clients start with one product and add others at renewal.
Card or direct debit through the checkout above, or by invoice against a purchase order for annual contracts. Enterprise is normally invoiced.
Several of these datasets are already live and free on this site, built from the same pipeline on the same cadence. Look at those first, then decide whether the full set is worth it.
See a live tool